Life AI Net
Start
Archiv
Rechner
Verzeichnis
Newsletter
Hot
Anmelden
Deutsch
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Start
Archiv
Rechner
Verzeichnis
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Anmelden
Start
Archiv
Rechner
Verzeichnis
More
Live
FierceBiotech
Pulnovo Medical scores $100M in finance round led by Medtronic
Lonza News
Lonza Group AG stock (CH0013841017): Why biopharma contract manufacturing now matters more for U.S. - AD HOC NEWS
10x Genomics Blog
Is Atera’s New Spatial Biology Platform Altering The Investment Case For 10x Genomics (TXG)? - simplywall.st
Brady Corporation
Milwaukee’s Brady Corp Buying Honeywell Division - Seehafer News
FierceBiotech
Foundation Medicine expands Bristol Myers Squibb collaboration with new diagnostic target
FierceBiotech
In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
FierceBiotech
Ray Therapeutics shines a light on $125M round targeting genetic eye therapy
FierceBiotech
Tortugas comes out of its shell with $106M to fund 4 phase 2-stage neuro drugs licensed from Asia
FierceBiotech
Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
BioWorld
Pricing standoff leaves Australian patients in limbo
BioWorld
Mabwell turns to Hong Kong to fund ADC ambitions
BioWorld
Xuanzhu shares dip despite phase III ALK inhibitor data
FierceBiotech
Pulnovo Medical scores $100M in finance round led by Medtronic
Lonza News
Lonza Group AG stock (CH0013841017): Why biopharma contract manufacturing now matters more for U.S. - AD HOC NEWS
10x Genomics Blog
Is Atera’s New Spatial Biology Platform Altering The Investment Case For 10x Genomics (TXG)? - simplywall.st
Brady Corporation
Milwaukee’s Brady Corp Buying Honeywell Division - Seehafer News
FierceBiotech
Foundation Medicine expands Bristol Myers Squibb collaboration with new diagnostic target
FierceBiotech
In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
FierceBiotech
Ray Therapeutics shines a light on $125M round targeting genetic eye therapy
FierceBiotech
Tortugas comes out of its shell with $106M to fund 4 phase 2-stage neuro drugs licensed from Asia
FierceBiotech
Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
BioWorld
Pricing standoff leaves Australian patients in limbo
BioWorld
Mabwell turns to Hong Kong to fund ADC ambitions
BioWorld
Xuanzhu shares dip despite phase III ALK inhibitor data
Archiv
Suchen
Suchen
Aktuell
Älteste
Löschen
@BioWorld
Gesamt
1062
Quelle
BioWorld
Suche
--
BioWorld
20. März 2026
FDA, NIH mark milestones toward reducing animal testing
BioWorld
20. März 2026
Treeline Biosciences reports TEAD degraders
BioWorld
20. März 2026
Muscarinic M4 receptor PAMs disclosed in Suven Life Sciences patent
BioWorld
20. März 2026
Omass Therapeutics identifies melanocortin MC2 receptor antagonists
BioWorld
20. März 2026
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld
19. März 2026
Appointments and advancements for March 19, 2026
BioWorld
19. März 2026
Financings for March 19, 2026
BioWorld
19. März 2026
In the clinic for March 19, 2026
BioWorld
19. März 2026
Other news to note for March 19, 2026
BioWorld
19. März 2026
Regulatory actions for March 19, 2026
BioWorld
19. März 2026
Innocare presents new VAV1 degradation inducers
BioWorld
19. März 2026
Group in Taiwan patents new peptides and lipid nanoparticles for cancer
BioWorld
19. März 2026
NOX4 inhibitors divulged in Boehringer Ingelheim patent
BioWorld
19. März 2026
Excalipoint closes $68.7M seed round for cancer T-cell engagers
BioWorld
18. März 2026
Appointments and advancements for March 18, 2026
BioWorld
18. März 2026
Financings for March 18, 2026
BioWorld
18. März 2026
In the clinic for March 18, 2026
BioWorld
18. März 2026
Other news to note for March 18, 2026
Zurück
13 / 59
Weiter